Institutional members access full text with Ovid®

Share this article on:

The Three Dermoglandular Flap Support in Reduction Mammaplasty

Pascone, Michele M.D.; Di Candia, Michele M.D.; Pascone, Christian M.D.

Plastic and Reconstructive Surgery: July 2012 - Volume 130 - Issue 1 - p 1e–10e
doi: 10.1097/PRS.0b013e31823ae90c
Breast: Original Articles

Background: Bilateral breast reduction is an established procedure performed to relieve the physical pain and psychological discomfort associated with heavy, pendulous breasts. Numerous techniques have been developed over the years with several refinements to obtain safe nipple-areola complex transposition and harmonious breast shape. Based on the experience of the senior author (M.P.), the three dermoglandular flap technique is proposed to achieve a safe and aesthetically pleasing breast reduction through the surgical concept of dermal support.

Methods: The authors analyzed the benefits of the three dermoglandular flap technique performed in a selected group of smoking patients with a potentially high risk of postoperative complications and high probability of breast ptosis recurrence (each patient had breast volume >1000 cc, breast nipple ptosis grade 3 on Regnault's scale, and body mass index >27). Blood supply to the nipple-areola complex was based on an inferior-central pedicle.

Results: Between 1995 and 2007, 47 smokers underwent bilateral breast reduction using the three dermoglandular flap technique. Their ages ranged from 37 to 63 years (mean, 49 years), and their average body mass index was 31.2 kg/m2 (range, 27 to 38). The overall complications rate was 14.9 percent. No wound breakdowns and no complete or partial necrosis of the nipple-areola complex was observed. Follow-up ranged from 18 to 48 months (mean, 32 months).

Conclusions: Three dermoglandular flap reduction mammaplasty produced good cone shape, soft texture, and fullness in the central and inferior pole with satisfactory breast projection and was stable over time. It offers a safe and practical approach in the treatment of challenging breast hypertrophy.

CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.

Bari, Italy

From the Department of Plastic and Reconstructive Surgery, Azienda Ospedaliera Universitaria Consorziale Policlinico, University of Bari.

Received for publication April 1, 2010; accepted January 12, 2011.

Presented at the 52nd Meeting of the Italian Society of Plastic, Reconstructive, and Aesthetic Surgery (SICPRE), in Florence, Italy, September 18 through 20, 2003.

Disclosure: The authors have no financial interest to declare in relation to the content of this article.

Michele Di Candia, M.D.; Department of Plastic and Reconstructive Surgery, Azienda Ospedaliera Consorziale Policlinico, University of Bari, Bari, Italy, info@micheledicandia.com

©2012American Society of Plastic Surgeons